CellSeed Inc
TSE:7776

Watchlist Manager
CellSeed Inc Logo
CellSeed Inc
TSE:7776
Watchlist
Price: 315 JPY -0.32% Market Closed
Market Cap: ¥10.9B

Operating Margin

-836.7%
Current
Declining
by 310.2%
vs 3-y average of -526.5%

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
-836.7%
=
Operating Income
¥-1B
/
Revenue
¥120.3m

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
-836.7%
=
Operating Income
¥-1B
/
Revenue
¥120.3m

Peer Comparison

Country Company Market Cap Operating
Margin
JP
CellSeed Inc
TSE:7776
10.9B JPY
Loading...
FR
Pharnext SCA
OTC:PNEXF
6T USD
Loading...
US
Abbvie Inc
NYSE:ABBV
389.3B USD
Loading...
US
Amgen Inc
NASDAQ:AMGN
187.3B USD
Loading...
US
Gilead Sciences Inc
NASDAQ:GILD
170.5B USD
Loading...
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
121.2B USD
Loading...
US
Epizyme Inc
F:EPE
94.1B EUR
Loading...
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
80.1B USD
Loading...
AU
CSL Ltd
ASX:CSL
87B AUD
Loading...
NL
argenx SE
XBRU:ARGX
42.4B EUR
Loading...
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
47.4B USD
Loading...

Market Distribution

Lower than 99% of companies in Japan
Percentile
1st
Based on 6 730 companies
1st percentile
-836.7%
Low
-125 500% — 4.2%
Typical Range
4.2% — 10.6%
High
10.6% — 9 743.7%
Distribution Statistics
Japan
Min -125 500%
30th Percentile 4.2%
Median 7%
70th Percentile 10.6%
Max 9 743.7%

CellSeed Inc
Glance View

Market Cap
10.9B JPY
Industry
Biotechnology

CellSeed Inc. develops regenerative medicine products. The company is headquartered in Koto-Ku, Tokyo-To and currently employs 44 full-time employees. The company went IPO on 2010-03-16. The firm operates in two business segments. The Regenerative Medical Support segment is engaged in the research, development, manufacture and sale of temperature-responsive cell incubators. The Cell Sheet Regeneration Medical segment is involved in the research and development of cell sheet regenerative medical products.

Intrinsic Value
30.6 JPY
Overvaluation 90%
Intrinsic Value
Price
What is Operating Margin?
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
How is Operating Margin calculated?

Operating Margin is calculated by dividing the Operating Income by the Revenue.

Operating Margin
-836.7%
=
Operating Income
¥-1B
/
Revenue
¥120.3m
What is CellSeed Inc's current Operating Margin?

The current Operating Margin for CellSeed Inc is -836.7%, which is below its 3-year median of -526.5%.

How has Operating Margin changed over time?

Over the last 3 years, CellSeed Inc’s Operating Margin has decreased from -621.4% to -836.7%. During this period, it reached a low of -836.7% on Oct 30, 2025 and a high of -367% on Dec 31, 2023.

Back to Top